Visual hallucination in Parkinson's disease with FDG PET

被引：73

作者：

Nagano-Saito, A

Washimi, Y

Arahata, Y

Iwai, K

Kawatsu, S

Ito, K

Nakamura, A

Abe, Y

Yamada, T

Kato, T

Kachi, T

机构：

[1] Natl Ctr Geriatr & Gerontol, Dept Brain Sci & Mol Imaging, Natl Inst Longev Sci, Obu, Aichi 4748522, Japan

[2] Chubu Natl Hosp, Dept Neurol, Obu, Japan

来源：

MOVEMENT DISORDERS | 2004年 / 19卷 / 07期

关键词：

Parkinson's disease; visual hallucination; F-18]fluorodeoxyglucose; FDG; positron emission tomography (PET);

D O I：

10.1002/mds.20129

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

To determine the characteristics of cerebral glucose metabolism in Parkinson's disease patients with visual hallucinations, group comparison studies using [F-18]fluorodeoxyglucose positron emission tomography were performed. Nondemented Parkinson's disease patients in advanced stages were classified into two groups: (1) patients without visual hallucinations; (2) patients with visual hallucinations. Compared to patients without hallucinations. the relative regional cerebral glucose metabolic rate was greater in the frontal areas in patients with visual hallucinations, and the increase reached a significant level in the left superior frontal gyrus. Relative frontal hypermetabolism may be a feature of Parkinson's disease patients with visual hallucinations. (C) 2004 Movement Disorder Society.

引用

页码：801 / 806

页数：6

共 50 条

[21] Executive processes in Parkinson's disease:: FDG-PET and network analysis
Lozza, C
Baron, JC
Eidelberg, D
Mentis, MJ
Carbon, M
Marié, RM
HUMAN BRAIN MAPPING, 2004, 22 (03) : 236 - 245
[22] FDG-PET related pattern expression and survival in Parkinson's disease
Marti-Andres, G.
Betech, V.
Prieto, E.
Espinoza-Vinces, C.
Riverol, M.
Luquin, M.
Arbizu, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S199 - S199
[23] FDG-PET findings of Parkinson's disease with mild cognitive impairment
Lee, M. -S.
Lyoo, C. H.
Jeong, Y.
Ryu, Y. H.
Rinne, J.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S156 - S157
[24] Relationship between vismispatial and vistioconstructive impairments and visual hallucination in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease
Petrovic, M
Zlatic, G
Ocic, G
Savic, A
Tomic, G
Knezevic, Z
Toncev, G
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S297 - S297
[25] Assessment of Parkinson disease with dementia by FDG-PET
Higashi, Y.
Miyaishi, M.
Tabata, M.
Sasaki, M.
Ishii, K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S186 - S186
[26] Cognitive functions in Parkinson's disease: Relation to disease severity and hallucination
Wakamori, Takaaki
Agari, Takashi
Yasuhara, Takao
Kameda, Masahiro
Kondo, Akihiko
Shinko, Aiko
Sasada, Susumu
Sasaki, Tatsuya
Furuta, Tomohisa
Date, Isao
PARKINSONISM & RELATED DISORDERS, 2014, 20 (04) : 415 - 420
[27] Tactile hallucination as hypnagogic hallucination in Parkinson disease patients
Komagamine, T.
Kokubun, N.
Suzuki, K.
Hirata, K.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 366 - 367
[28] Combined dopamine transporter and FDG PET in dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease
Johnson, KA
Rentz, DM
Moran, EK
Becker, JA
Schlossmacher, MG
Sudarsky, L
Fischman, AJ
NEUROLOGY, 2004, 62 (07) : A300 - A300
[29] 18F-FDG PET/CT imaging in the diagnosis of Parkinson's disease
Mao, Z.
Ji, S.
Yang, Q.
Ye, H.
Xue, Z.
MOVEMENT DISORDERS, 2015, 30 : S18 - S18
[30] Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia
Walker, Zuzana
Gandolfo, Federica
Orini, Stefania
Garibotto, Valentina
Agosta, Federica
Arbizu, Javier
Bouwman, Femke
Drzezga, Alexander
Nestor, Peter
Boccardi, Marina
Altomare, Daniele
Festari, Cristina
Nobili, Flavio
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (09) : 1534 - 1545

← 1 2 3 4 5 →